NCT01195389Unknown不适用
A Randomized, Single-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Efficacy of the Application of Magnetic Fields Using the Resonator for the Treatment of Alzheimer's Disease in Addition to Standard of Care
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Alzheimer's Disease Assessment Scale-Cog (ADAS-cog)
研究概览
简要总结
The purpose of this study is to determine if low level magnetic fields can help to improve memory in patients diagnosed with Alzheimer's dementia.
详细描述
The purpose of this pilot study is to determine whether application of magnetic fields generated by the Resonator result in statistically significant improvements in cognitive functioning and memory in patients with a diagnosis of Alzheimer's dementia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Current diagnosis of Alzheimer's Disease appropriately documented by the patients physician and/or neurologist
- •Documentation verifying that other generally recognized causes of dementia have been ruled out by prior physician evaluations
- •Mild to Moderate Dementia, as evidenced by a score of not less than 12 nor greater than 26 on the Mini Mental Status Exam (MMSE).
- •Subject is ambulatory.
- •A Study Partner who can attend all study visits with the subject. Study Partner being defined as an adult who has at least 10 hours/week of contact with the subject, and can accompany the subject to all testing and treatment study visits.
- •Stable "anti-dementia" medication regimen without significant side effects for at least 3 months, and on stable medication (unrelated to anti-dementia) without significant side effects for at least 1 month; willingness and ability to maintain the stable medication regimen throughout the course of the study.
- •Willingness and ability to present to the testing center for all study evaluations
- •Willingness and ability to present to the treatment center for all study treatments (exposure to the Resonator™)
- •Willingness to maintain stable diet and activity regimen for the duration of the study.
- •Willing and able to abstain from partaking in any non-essential (not physician ordered) existing or new treatments to improve cognition and mental functioning
- •Willing and able to abstain from any medications that could affect cognition and mental functioning during the course of the study
- •Male or female.
- •Any ethnic background.
- •Age 55 and older.
排除标准
- •Change in anti-dementia medical regimen within 3 months prior to initiation of study.
- •Confirmed diagnosis other non-Alzheimer's type of dementia
- •Significant neurologic or psychiatric illness other than Alzheimer's disease
- •Unstable cardiac disease, such as any history of cardiac arrhythmias (including atrial fibrillation, ventricular fibrillation, or irregular atrial-ventricular conduction time), or any incidences of congestive heart failure, or myocardial infarction, within the last six months.
- •Previous surgical interventions involving prosthetics or implants comprised of ferrous metals, or pacemakers, vagus nerve stimulators, or other functional electrical stimulators such as those commonly used for pain.
- •Reported consumption of more than 14 alcoholic drinks per week.
- •Uncontrolled hypertension.
- •Uncontrolled atrial fibrillation or other uncontrolled arrhythmias, e.g. tachycardia, bradycardia.
- •Uncontrolled seizure disorder.
- •History of seizures or usage of anti-seizure medications that, in the opinion of the investigator, participation in this trial would represent a risk to the subject.
- •Uncontrolled, unstable, or untreated medical conditions which may significantly impact the subject's health or ability to complete the entire study, in the opinion of the investigator.
结局指标
主要结局
Alzheimer's Disease Assessment Scale-Cog (ADAS-cog)
时间窗: end of treatment at 12 weeks
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
撤回
不适用
Study of Magnetic Fields to Treat Alzheimer's DiseaseAlzheimer's DiseaseNCT01313806pico-tesla Magnetic Therapies, LLC30
已完成
2 期
Study of Magnetic Fields for Treatment of Parkinson's DiseaseParkinson's DiseaseNCT00779155pico-tesla Magnetic Therapies, LLC12
已完成
不适用
Low Field Magnetic Stimulation for Treatment Resistant DepressionTreatment Resistant DepressionNCT01944644Weill Medical College of Cornell University66
已完成
不适用
A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in AutismAutism Spectrum DisorderNCT01985308Wave Neuroscience28
已完成
不适用
Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's DiseaseAlzheimer's DiseaseNCT01847586Centre for Addiction and Mental Health49